|
On June 29, 2007 GeneraMedix Inc. received approval
from the U.S. Food and Drug Administration (FDA) for its
Abbreviated New Drug Application (ANDA) for Ampicillin
and Sulbactam for Injection, USP. GeneraMedix will
market Ampicillin and Sulbactam in 1.5 g and 3 g vials. The
product is AP rated and equivalent to the brand, Unasyn® by Pfizer.
For product information please contact:
GeneraMedix Inc. Customer Service
1-866–GENERA–1
1-866-436-3721
|
